Parenteral dexamethasone for acute severe migraine headache: meta-analysis of randomised controlled trials for preventing recurrence

Colman, Ian; Friedman, Benjamin W.; Brown, Michael D.; Innes, Grant D.; Grafstein, Eric; Roberts, Ted E.; Rowe, Brian H.
June 2008
BMJ: British Medical Journal (International Edition);6/14/2008, Vol. 336 Issue 7657, p1359
Academic Journal
Objective To examine the effectiveness of parenteral corticosteroids for the relief of acute severe migraine headache and prevention of recurrent headaches. Design Meta-analysis. Data sources Electronic databases (Cochrane Central Register of Controlled Trials, Medline, Embase, LILACS, and CINAHL), conference proceedings, clinical practice guidelines, contacts with industry, and correspondence with authors. Selection criteria Randomised controlled trials in which corticosteroids (alone orcombined with standard abortive therapy) were compared with placebo or any other standard treatment for acute migraine in adults. Review methods Two reviewers independently assessed relevance, inclusion, and study quality, Weighted mean differences and relative risks were calculated and are reported with 95% confidence intervals. Results From 666 potentially relevant abstracts, seven studies met the inclusion criteria. All included trials used standard abortive therapy and subsequently compared single dose parenteral dexamethasone with placebo, examining pain relief and recurrence of headache within 72 hours. Dexamethasone and placebo provided similar pain reduction (weighted mean difference 0.37, 95% confidence interval -0.20 to 0.94). Dexamethasone was, however, more effective than placebo in reducing recurrence rates (relative risk 0.74, 95% confidence interval 0.60 to 0.90). Side effect profiles between dexamethasone and placebo groups were similar. Conclusion When added to standard abortive therapy for migraine headache, single dose parenteral dexamethasone ¡s associated with a 26% relative reduction in headache recurrence (number needed to treat=9) within 72 hours.


Related Articles

  • Topical Treatments for Scalp Psoriasis. Warren, Richard B.; Brown, Benjamin C.; Griffiths, Christopher E. M. // Drugs;2008, Vol. 68 Issue 16, p2293 

    Psoriasis is a common, chronic inflammatory skin disease that affects the scalp more commonly than any other site. Scalp psoriasis causes significant psychosocial disability as it is highly visible and can, on occasion, extend onto the face. Furthermore, current treatment regimens are messy,...

  • Comparison of fluoroscopically guided and blind corticosteroid injections for greater trochanteric pain syndrome: multicentre randomised controlled trial. Cohen, Steven P.; Strassels, Scott A.; Foster, Leslie; Marvel, John; Williams, Kayode; Crooks, Matthew; Gross, Andrew; Kurihara, Connie; Cuong Nguyen; Williams, Necia // BMJ: British Medical Journal (Overseas & Retired Doctors Edition;4/25/2009, Vol. 338 Issue 7701, p986 

    ABSTRACT Objective To determine whether fluoroscopic guidance improves outcomes of injections for greater trochanteric pain syndrome. Design Multicentre double blind randomised controlled study. Setting Three academic and military treatment facilities in the United States and Germany....

  • Effect of Corticosteroids on the Biomechanical Strength of Rat Rotator Cuff Tendon. Mikolyzk, David K.; Wei, Anthony S.; Tonino, Pietro; Marra, Guido; Williams, Denis A.; Himes, Ryan D.; Wezeman, Frederick H.; Callaci, John J. // Journal of Bone & Joint Surgery, American Volume;May2009, Vol. 91-A Issue 5, p1172 

    Background: The effect of corticosteroids on tendon properties is poorly understood, and current data are contradictory and diverse. The biomechanical effect of steroids on rotator cuff tendon has not been studied, to our knowledge. The current study was undertaken to characterize the...

  • Novel Diabetes Treatments: New and Future Developments. Buckley, Rita // MD Conference Express;Aug2011, p22 

    The article reports on research which was conducted by Ernest M. Wright of the David Geffen School of Medicine at the University of California in Los Angeles, California on sodium glucose cotransporter 2 (SGLT2) inhibitors which are used in the treatment of hyperglycemia in diabetes. Research...

  • Multicenter International Lymphangioleiomyomatosis Efficacy and Safety of Sirolimus Trial.  // MD Conference Express;Aug2011, p10 

    The article reports on research which was conducted by physician Francis X. McCormack of the University of Cincinnati in Cincinnati, Ohio to investigate the safety and efficacy of using the drug sirolimus to improving lung function in lymphangioleiomyomatosis. McCormack's research found that...

  • Naftidrofuryl for intermittent claudication: meta-analysis based on individual patient data. De Backer, T.; Stichele, R. Vander; Lehert, P.; Van Bortel, L. // BMJ: British Medical Journal (Overseas & Retired Doctors Edition;3/21/2009, p703 

    The article focuses on the results of research which was conducted in an effort to determine the efficacy and safety of the oral vasoactive drug naftidrofuryl when compared with placebo in improving walking distance in patients with intermittent claudication. Researchers examined medical...

  • Evaluation of Vitreous Clearance and Potential Retinal Toxicity of Intravitreal Lornoxicam (Xefo). Diakonis, Vasilios F.; Tsourdou, Antigoni; Tzatzarakis, Manolis N.; Tsika, Chrysanthi; Charisis, Spyridon; Naoumidi, Irini; Plainis, Sotiris; Tsilimbaris, Miltiadis K. // Journal of Ocular Pharmacology & Therapeutics;Sep2013, Vol. 29 Issue 7, p627 

    Purpose: To evaluate the vitreous clearance and toxicological profile of commercially available lornoxicam (Xefo), after a single intravitreal injection in rabbits. Methods: Twenty-five male albino rabbits (10 rabbits were used for retinal toxicity evaluation, while 15 rabbits were used to...

  • The Effect of Ocular Pigmentation on Transscleral Delivery of Triamcinolone Acetonide. Du, Wennan; Sun, Shumao; Xu, Yu; Li, Jie; Zhao, Chunhui; Lan, Bifei; Chen, Hao; Cheng, Lingyun // Journal of Ocular Pharmacology & Therapeutics;Sep2013, Vol. 29 Issue 7, p633 

    Purpose: To determine the capacity and kinetics of the binding between triamcinolone acetonide (TA) and the ocular pigment for a better understanding of the transscleral delivery. Methods: In the in vitro study, natural melanin ( sepia officinalis, Sigma-Aldrich) was incubated at 37°C with...

  • Heart Benefits from Two-Drug Therapy.  // Journal of Gerontological Nursing;Feb2009, Vol. 35 Issue 2, p8 

    The article reports on the results of the Avoiding Cardiovascular Events through Combination Therapy in Patients Living with Systolic Hypertension (ACCOMPLISH) trial, which was funded by the pharmaceutical firm Novartis. The results of the trial, which involved 11,506 participants and compared...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics